Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cambrex Corp (CBM)

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cambrex Corp ONE MEADOWLANDS PLZ EAST RUTHERFORD NJ 07073 USA

P: 201-804-3000 F: 201-804-9852

Description:

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.

Key Statistics

Overview:

Market Capitalization, $K 2,023,102
Shares Outstanding, K 33,724
Annual Sales, $ 532,090 K
Annual Net Income, $ 92,420 K
Last Quarter Sales, $ 148,560 K
Last Quarter Net Income, $ 9,550 K
60-Month Beta 2.13
% of Insider Shareholders 1.41%
% of Institutional Shareholders 90.96%
Float, K 33,248
% Float 98.59%

Growth:

1-Year Return 21.78%
3-Year Return 14.27%
5-Year Return 153.55%
5-Year Revenue Growth 67.23%
5-Year Earnings Growth 214.77%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.31 on 05/02/19
Next Earnings Date 11/14/19
Earnings Per Share ttm 0.60
EPS Growth vs. Prev Year -68.35%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 14.000 on 05/04/07
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 06/25/98

CBM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 23.32
Price/Earnings to Growth N/A
Return-on-Equity % 5.38%
Return-on-Assets % 2.50%
Profit Margin % 17.37
Net Margin % 4.42
Debt/Equity 0.78
Price/Sales 3.80
Price/Cash Flow 15.36
Price/Book 2.99
Book Value/Share 20.04
Interest Coverage 28.66
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar